Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Lokelma (sodium zirconium cyclosilicate)
pCPA File Number:
21193
Negotiation Status:
Negotiations were not pursued
Indication(s):
hyperkalemia
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
SR0612-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
2020-04-16